ATE225400T1 - Verwendung der leserahmen der adenoviralen e4- region zur verbesserung der genexpression - Google Patents
Verwendung der leserahmen der adenoviralen e4- region zur verbesserung der genexpressionInfo
- Publication number
- ATE225400T1 ATE225400T1 AT99401645T AT99401645T ATE225400T1 AT E225400 T1 ATE225400 T1 AT E225400T1 AT 99401645 T AT99401645 T AT 99401645T AT 99401645 T AT99401645 T AT 99401645T AT E225400 T1 ATE225400 T1 AT E225400T1
- Authority
- AT
- Austria
- Prior art keywords
- expression
- adenoviral
- improve
- gene expression
- orf6
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/10011—Adenoviridae
- C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
- C12N2710/10322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/10011—Adenoviridae
- C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
- C12N2710/10341—Use of virus, viral particle or viral elements as a vector
- C12N2710/10343—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
- C12N2830/008—Vector systems having a special element relevant for transcription cell type or tissue specific enhancer/promoter combination
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2840/00—Vectors comprising a special translation-regulating system
- C12N2840/44—Vectors comprising a special translation-regulating system being a specific part of the splice mechanism, e.g. donor, acceptor
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Virology (AREA)
- Molecular Biology (AREA)
- General Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Biophysics (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Diabetes (AREA)
- Biochemistry (AREA)
- Zoology (AREA)
- Immunology (AREA)
- Hematology (AREA)
- Microbiology (AREA)
- Communicable Diseases (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Oncology (AREA)
- Gastroenterology & Hepatology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Obesity (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP98401722 | 1998-07-07 | ||
EP98402825 | 1998-11-13 |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE225400T1 true ATE225400T1 (de) | 2002-10-15 |
Family
ID=26151663
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT99401645T ATE225400T1 (de) | 1998-07-07 | 1999-07-01 | Verwendung der leserahmen der adenoviralen e4- region zur verbesserung der genexpression |
AT01124236T ATE258228T1 (de) | 1998-07-07 | 1999-07-01 | Verwendung der leserahmen der adenoviralen e4- region zur verbesserung der genexpression |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT01124236T ATE258228T1 (de) | 1998-07-07 | 1999-07-01 | Verwendung der leserahmen der adenoviralen e4- region zur verbesserung der genexpression |
Country Status (11)
Country | Link |
---|---|
US (1) | US6475480B1 (de) |
EP (2) | EP0974668B1 (de) |
JP (1) | JP2000106875A (de) |
AT (2) | ATE225400T1 (de) |
AU (1) | AU756607B2 (de) |
CA (1) | CA2276791A1 (de) |
DE (2) | DE69914382T2 (de) |
DK (2) | DK0974668T3 (de) |
ES (2) | ES2180258T3 (de) |
HK (1) | HK1043390A1 (de) |
PT (2) | PT1199368E (de) |
Families Citing this family (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6225113B1 (en) * | 1998-12-04 | 2001-05-01 | Genvec, Inc. | Use of trans-activation and cis-activation to modulate the persistence of expression of a transgene in an at least E4-deficient adenovirus |
EP1301612A2 (de) * | 2000-05-31 | 2003-04-16 | Genvec, Inc. | Verfahren und zusammenfassung zur zielrichtung von adenoviralen vektoren |
EP1203819A3 (de) | 2000-10-06 | 2002-08-07 | Transgene S.A. | Entzündungshemmende Vektoren |
WO2004018627A2 (en) * | 2002-08-22 | 2004-03-04 | Merck & Co., Inc. | Methods for propagating adenovirus and virus produced thereby |
DE602004031681D1 (de) | 2003-07-21 | 2011-04-14 | Transgene Sa | Multifunktionelle Cytokine |
CA2592699C (en) * | 2004-12-31 | 2023-02-21 | Per Sonne Holm | Method for reversing multiple resistance in animal cells |
US20080166322A1 (en) * | 2006-12-08 | 2008-07-10 | Atkinson Richard L | Methods for producing an adenovirus type 5 gene transfer vector |
US8465732B2 (en) * | 2007-01-19 | 2013-06-18 | Cornell Research Foundation, Inc. | Endothelial cells expressing adenovirus E4ORF1 and methods of use thereof |
SG187785A1 (en) | 2010-08-16 | 2013-03-28 | Salk Inst For Biological Studi | Anti-cancer adenoviruses |
KR101522341B1 (ko) * | 2012-10-02 | 2015-05-21 | 국립암센터 | 신규한 조건부-복제 가능 아데노바이러스 및 그의 제조 방법 |
US9657076B2 (en) | 2012-10-23 | 2017-05-23 | Emory University | GM-CSF and IL-4 conjugates, compositions, and methods related thereto |
WO2014153204A1 (en) | 2013-03-14 | 2014-09-25 | Salk Institute For Biological Studies | Oncolytic adenovirus compositions |
WO2017147269A1 (en) | 2016-02-23 | 2017-08-31 | Salk Institute For Biological Studies | Exogenous gene expression in therapeutic adenovirus for minimal impact on viral kinetics |
WO2017147265A1 (en) | 2016-02-23 | 2017-08-31 | Salk Institute For Biological Studies | High throughput assay for measuring adenovirus replication kinetics |
US11826423B2 (en) | 2016-11-16 | 2023-11-28 | Immunomic Therapeutics, Inc. | Nucleic acids for treatment of allergies |
EP3532082A4 (de) | 2016-12-12 | 2020-08-26 | Salk Institute for Biological Studies | Auf tumoren gerichtete synthetische adenoviren und verwendungen davon |
US11203629B2 (en) | 2017-04-22 | 2021-12-21 | Immunomic Therapeutics, Inc. | LAMP constructs |
AU2018263923B9 (en) | 2017-05-02 | 2024-09-19 | Immunomic Therapeutics, Inc. | LAMP (lysosomal associated membrane protein) constructs comprising cancer antigens |
AU2018266705B2 (en) | 2017-05-08 | 2023-05-04 | Gritstone Bio, Inc. | Alphavirus neoantigen vectors |
WO2019222281A1 (en) | 2018-05-15 | 2019-11-21 | Immunomic Therapeutics, Inc | Improved lamp constructs comprising allergens |
AU2020282369A1 (en) | 2019-05-30 | 2022-01-20 | Gritstone Bio, Inc. | Modified adenoviruses |
CA3153850A1 (en) | 2019-10-18 | 2021-04-22 | Teri Heiland | Improved lamp constructs comprising cancer antigens |
CN110714027A (zh) * | 2019-10-28 | 2020-01-21 | 嘉铭(固安)生物科技有限公司 | 一种表达质粒、用于包装二代腺病毒的细胞株及其应用 |
CN110656090B (zh) * | 2019-10-28 | 2023-06-30 | 嘉兴安宇生物科技有限公司 | 一种表达质粒、用于包装容量增加的二代腺病毒的细胞株及其应用 |
WO2022007800A1 (zh) * | 2020-07-06 | 2022-01-13 | 嘉兴安宇生物科技有限公司 | 一种非洲猪瘟的重组腺病毒疫苗及其构建方法 |
KR20220106072A (ko) | 2021-01-21 | 2022-07-28 | 주식회사 셀리드 | 복제가능 아데노바이러스를 포함하지 않는 신규 아데노바이러스 벡터 및 이의 용도 |
CN119233982A (zh) | 2022-04-10 | 2024-12-31 | 免疫治疗有限公司 | 包含免疫应答增强基因的双顺反子lamp构建体及其使用方法 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5670488A (en) * | 1992-12-03 | 1997-09-23 | Genzyme Corporation | Adenovirus vector for gene therapy |
EP0905253A3 (de) * | 1992-12-03 | 2000-11-02 | Genzyme Corporation | Von allen E4-ORF ausgenommen ORF6 deletierte Adenovirus-Vector |
FR2726285B1 (fr) * | 1994-10-28 | 1996-11-29 | Centre Nat Rech Scient | Adenovirus depourvus de particules contaminantes viables, preparation et utilisation |
US5756283A (en) * | 1995-06-05 | 1998-05-26 | The Trustees Of The University Of Pennsylvania | Method for improved production of recombinant adeno-associated viruses for gene therapy |
WO1998021350A1 (en) * | 1996-11-13 | 1998-05-22 | Board Of Regents, The University Of Texas System | Diminishing viral gene expression by promoter replacement |
US6100086A (en) * | 1997-04-14 | 2000-08-08 | Genzyme Corporation | Transgene expression systems |
US5981275A (en) * | 1997-04-14 | 1999-11-09 | Genzyme Corporation | Transgene expression system for increased persistence |
-
1999
- 1999-07-01 ES ES99401645T patent/ES2180258T3/es not_active Expired - Lifetime
- 1999-07-01 DE DE69914382T patent/DE69914382T2/de not_active Expired - Fee Related
- 1999-07-01 DK DK99401645T patent/DK0974668T3/da active
- 1999-07-01 PT PT01124236T patent/PT1199368E/pt unknown
- 1999-07-01 DK DK01124236T patent/DK1199368T3/da active
- 1999-07-01 AT AT99401645T patent/ATE225400T1/de not_active IP Right Cessation
- 1999-07-01 AT AT01124236T patent/ATE258228T1/de not_active IP Right Cessation
- 1999-07-01 EP EP99401645A patent/EP0974668B1/de not_active Expired - Lifetime
- 1999-07-01 EP EP01124236A patent/EP1199368B1/de not_active Expired - Lifetime
- 1999-07-01 DE DE69903229T patent/DE69903229T2/de not_active Expired - Lifetime
- 1999-07-01 ES ES01124236T patent/ES2210081T3/es not_active Expired - Lifetime
- 1999-07-01 PT PT99401645T patent/PT974668E/pt unknown
- 1999-07-06 AU AU38009/99A patent/AU756607B2/en not_active Ceased
- 1999-07-06 US US09/348,049 patent/US6475480B1/en not_active Expired - Fee Related
- 1999-07-06 CA CA002276791A patent/CA2276791A1/en not_active Abandoned
- 1999-07-07 JP JP11227880A patent/JP2000106875A/ja active Pending
-
2002
- 2002-07-12 HK HK02105186.1A patent/HK1043390A1/zh unknown
Also Published As
Publication number | Publication date |
---|---|
PT1199368E (pt) | 2004-04-30 |
AU756607B2 (en) | 2003-01-16 |
ES2180258T3 (es) | 2003-02-01 |
DK0974668T3 (da) | 2002-11-11 |
DE69914382T2 (de) | 2004-11-04 |
US6475480B1 (en) | 2002-11-05 |
EP0974668A1 (de) | 2000-01-26 |
DK1199368T3 (da) | 2004-04-13 |
ES2210081T3 (es) | 2004-07-01 |
JP2000106875A (ja) | 2000-04-18 |
EP0974668B1 (de) | 2002-10-02 |
DE69914382D1 (de) | 2004-02-26 |
PT974668E (pt) | 2003-01-31 |
ATE258228T1 (de) | 2004-02-15 |
DE69903229T2 (de) | 2003-06-26 |
DE69903229D1 (de) | 2002-11-07 |
EP1199368A2 (de) | 2002-04-24 |
EP1199368A3 (de) | 2002-07-17 |
HK1043390A1 (zh) | 2002-09-13 |
AU3800999A (en) | 2000-06-08 |
CA2276791A1 (en) | 2000-01-07 |
EP1199368B1 (de) | 2004-01-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE225400T1 (de) | Verwendung der leserahmen der adenoviralen e4- region zur verbesserung der genexpression | |
PL397823A1 (pl) | Sposób identyfikacji serotypu sekwencji wirusa stowarzyszonego z adenowirusem (AAV), zestaw diagnostyczny, sposób izolacji nowych wirusów, nowy serotyp wirusa, wyizolowane wirusy, białka obejmujące fragment białka kapsydu AAV, sztuczne białka, zrekombinowany wirus, cząsteczki, sposób wytwarzania zrekombinowanych wirusów, komórki gospodarza, kompozycje, sposób dostarczania transgenu, wyizolowany AAV, rekombinowana komórka, sposób wytwarzania rekombinowanego wirusa, zastosowanie wirusa | |
WO2005001103A3 (en) | Methods of generating chimeric adenoviruses and uses for such chimeric adenoviruses | |
WO2001083692A3 (en) | Recombinant aav vectors with aav5 capsids and aav5 vectors pseudotyped in heterologous capsids | |
SI1496944T1 (sl) | Izboljšani sistemi ekspresije RAAV za genetsko modifikacijo specifičnih kapsidnih proteinov | |
ATE286138T1 (de) | Zusammensetzungen und verfahren zur helfer-freien herstellung von rekombinante adeno-assoziierten viren | |
CA2305623A1 (fr) | Circovirus porcins, vaccins et reactifs de diagnostic | |
DK1127150T3 (da) | Nucleinsyresekvenser fra det adeno-associerede virus af serotype 1 samt vektorer og værtsceller, der indeholder disse | |
AUPN477695A0 (en) | Gene therapy | |
ES2337768T3 (es) | Metodo para purificar adenovirus. | |
CA2323862A1 (en) | Maturation of somatic embryos | |
WO2006116267A3 (en) | Cell-specific molecule and method for importing dna into osteoblast nuclei | |
WO1998055639A3 (fr) | Vecteurs adenoviraux recombinants comprenant une sequence d'epissage | |
CA2167578A1 (en) | Chicken anemia virus mutants and vaccines and uses based on the viral proteins vp1, vp2 and vp3 or sequences of that virus coding therefor | |
ATE377088T1 (de) | Promotoren zur expression in modifiziertem vaccinia virus ankara | |
EP0752888A4 (de) | NUKLEOTID- AMINOSÄURESEQUENZEN DER HERPEVIREN gB,gC UND gD AUS HUND UND IHRE VERWENDUNGEN | |
DE69929530D1 (de) | Attenuierte pferdeherpesvirus | |
WO2005010149A3 (en) | Subgroup b adenoviral vectors for treating disease | |
MXPA02012593A (es) | Particulas de tipo virus del virus de la diarrea viral bovina. | |
DE69031803D1 (de) | Verfahren und nukleinsäuresequenzen zur expression des zellulose-synthase-operons | |
WO2006086357A3 (en) | Adenovirus serotype 36 vectors, nucleic acid and viruses produced thereby | |
EP1845163A3 (de) | Adeno-assoziierte Virus-Serotyp-I-Nukleinsäuresequenzen und diese enthaltende Vektoren und Wirtszellen | |
EP4407025A3 (de) | Adenovirus mit modifiziertem adenovirus-hexon-protein | |
WO2003031633A3 (de) | Adenovirales vektorsystem | |
Agrawal et al. | 800. Generation of Recombinant Skin In Vitro by Adeno-Associated Virus Type 2 Vector Transduction |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 0974668 Country of ref document: EP |
|
REN | Ceased due to non-payment of the annual fee |